Nathalie Andrieu-Abadie

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Cancers

International journal of molecular sciences

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Océane Dainese-Marque, Virginie Garcia, Nathalie Andrieu-Abadie, Joëlle Riond
Contribution of Keratinocytes in Skin Cancer Initiation and Progression. International journal of molecular sciences 25 (16) (2024)
Océane Dainese-Marque, Virginie Garcia, Nathalie Andrieu-Abadie, Joëlle Riond
Contribution of Keratinocytes in Skin Cancer Initiation and Progression. International journal of molecular sciences 25 (16) (2024)
Patricia Dubot, Leonardo Astudillo, Nicole Therville, Lorry Carrié, Magali Pettazzoni, David Cheillan, Jerome Stirnemann, Thierry Levade, Nathalie Andrieu-Abadie, Frédérique Sabourdy
Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer. Cancers 14 (19) (2022)
Anne Montfort, Florie Bertrand, Julia Rochotte, Julia Gilhodes, Thomas Filleron, Jean Milhès, Carine Dufau, Caroline Imbert, Joëlle Riond, Marie Tosolini, Christopher J Clarke, Florent Dufour, Andrei A Constantinescu, Nilton De França Junior, Virginie Garcia, Michel Record, Pierre Cordelier, Pierre Brousset, Philippe Rochaix, Sandrine Silvente-Poirot, Nicole Therville, Nathalie Andrieu-Abadie, Thierry Levade, Yusuf A Hannun, Hervé Benoist, Nicolas Meyer, Olivier Micheau, Céline Colacios, Bruno Ségui
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy. Cancer immunology research 9 (5) (2021)
Anne Montfort, Thomas Filleron, Mathieu Virazels, Carine Dufau, Jean Milhès, Cécile Pagès, Pascale Olivier, Maha Ayyoub, Muriel Mounier, Amélie Lusque, Stéphanie Brayer, Jean-Pierre Delord, Nathalie Andrieu-Abadie, Thierry Levade, Céline Colacios, Bruno Ségui, Nicolas Meyer
Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (4) (2020)
Laurence Pellerin, Lorry Carrié, Carine Dufau, Laurence Nieto, Bruno Ségui, Thierry Levade, Joëlle Riond, Nathalie Andrieu-Abadie
Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives. Cancers 12 (11) (2020)
Lorry Carrié, Mathieu Virazels, Carine Dufau, Anne Montfort, Thierry Levade, Bruno Ségui, Nathalie Andrieu-Abadie
New Insights into the Role of Sphingolipid Metabolism in Melanoma. Cells 9 (9) (2020)
Caroline Imbert, Anne Montfort, Marine Fraisse, Elie Marcheteau, Julia Gilhodes, Elodie Martin, Florie Bertrand, Marlène Marcellin, Odile Burlet-Schiltz, Anne Gonzalez de Peredo, Virginie Garcia, Stéphane Carpentier, Sophie Tartare-Deckert, Pierre Brousset, Philippe Rochaix, Florent Puisset, Thomas Filleron, Nicolas Meyer, Laurence Lamant, Thierry Levade, Bruno Ségui, Nathalie Andrieu-Abadie, Céline Colacios
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1. Nature communications 11 (1) (2020)
David Garandeau, Justine Noujarède, Justine Leclerc, Caroline Imbert, Virginie Garcia, Marie-Lise Bats, Florian Rambow, Julia Gilhodes, Thomas Filleron, Nicolas Meyer, Stéphanie Brayer, Silvia Arcucci, Sophie Tartare-Deckert, Bruno Ségui, Jean-Christophe Marine, Thierry Levade, Corine Bertolotto, Nathalie Andrieu-Abadie
Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas. Molecular cancer therapeutics 18 (2) (2018)

Nathalie Andrieu-Abadie.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nathalie Andrieu-Abadie